3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Pancreatic Neoplasms
12
Neoplasms
3
Pancreatic Cancer Non-resectable
1
Pancreatic Cancer Metastatic
1
Neoplasm Metastasis
1
Gastro-enteropancreatic neuroendocrine tumor
1
Diabetes Mellitus, Insulin-Dependent, 12
1
Colorectal Neoplasms
1
Carcinoma, Pancreatic Ductal
1
Carcinoma, Islet Cell
1
Adenocarcinoma
1
Interventions
pamrevlumab
1
folfirinox
1
Leucovorin
1
Irinotecan
1
Gemcitabine
1
Fluorouracil
1
Albumin-Bound Paclitaxel
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Has results
×
Pancreatic Cancer Non-resectable
×
folfirinox
×
Clear all
NCT03941093
2024-11-05
LAPIS
Kyntra Bio
Phase 3
Completed
284 enrolled
14 charts